IBRUTINIB TREATMENT DOESN'T INDUCE TP53 CLONAL EVOLUTION IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Cafforio, L.
Cappelli, L. V.
Del Giudice, I.
Ilari, C.
Raponi, S.
De Propris, M. S.
Mariglia, P.
Piciocchi, A.
Arena, V.
Vignetti, M.
Mauro, F. R.
Guarini, A.
Foa, R.
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Hematol, Rome, Italy
[2] GIMEMA Data Ctr, Rome, Italy
[3] GIMEMA Fdn, Rome, Italy
[4] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B002
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia
    Cafforio, Luciana
    Raponi, Sara
    Cappelli, Luca Vincenzo
    Ilari, Caterina
    Soscia, Roberta
    De Propris, Maria Stefania
    Mariglia, Paola
    Rigolin, Gian Matteo
    Bardi, Antonella
    Peragine, Nadia
    Piciocchi, Alfonso
    Arena, Valentina
    Mauro, Francesca Romana
    Cuneo, Antonio
    Guarini, Anna
    Foa, Robin
    Del Giudice, Ilaria
    HAEMATOLOGICA, 2022, 107 (01) : 334 - 337
  • [2] TP53 Clonal and Subclonal Architecture in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment
    Del Giudice, Ilaria
    Cafforio, Luciana
    Cappelli, Luca Vincenzo
    Ilari, Caterina
    Raponi, Sara
    De Propris, Maria Stefania
    Mariglia, Paola
    Mauro, Francesca Romana
    Vignetti, Marco
    Guarini, Anna
    Foa, Robin
    BLOOD, 2018, 132
  • [3] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
    Ahn, Inhye E.
    Tian, Xin
    Wiestner, Adrian
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
  • [4] TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IMMUNOCHEMOTHERAPY AND IBRUTINIB
    Cafforio, L.
    Cappelli, L. V.
    Del Giudice, I.
    Ilari, C.
    Raponi, S.
    Mariglia, P.
    De Propris, M. S.
    Filetti, M.
    Mauro, F. R.
    Foa, R.
    Guarini, A.
    HAEMATOLOGICA, 2018, 103 : S27 - S27
  • [5] TP53 Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?
    Bomben, Riccardo
    Zucchetto, Antonella
    Gentile, Massimo
    Gattei, Valter
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4462 - 4464
  • [6] RELATIONSHIP BETWEEN THERAPY AND CLONAL EVOLUTION OF TP53 ABNORMALITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Malcikova, J.
    Smardova, J.
    Kuglik, P.
    Brychtova, Y.
    Doubek, M.
    Kotaskova, J.
    Tichy, B.
    Pospisilova, S.
    Mayer, J.
    Trbusek, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 364 - 365
  • [7] Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation
    Bracher, Susanne
    Fuhrmann, Irene
    Jeromin, Sabine
    Nadarajah, Niroshan
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    Stengel, Anna
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 12247 - 12252
  • [8] Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation
    Susanne Bracher
    Irene Fuhrmann
    Sabine Jeromin
    Niroshan Nadarajah
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Anna Stengel
    Molecular Biology Reports, 2022, 49 : 12247 - 12252
  • [9] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [10] Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
    J Malcikova
    K Stano-Kozubik
    B Tichy
    B Kantorova
    S Pavlova
    N Tom
    L Radova
    J Smardova
    F Pardy
    M Doubek
    Y Brychtova
    M Mraz
    K Plevova
    E Diviskova
    A Oltova
    J Mayer
    S Pospisilova
    M Trbusek
    Leukemia, 2015, 29 : 877 - 885
12345